FAK(Ab-397) Antibody 21208 from Signalway Antibody LLC | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
Signalway Antibody LLC for
FAK(Ab-397) Antibody

The FAK(Ab-397) Antibody from Signalway Antibody LLC is a Rabbit Polyclonal antibody to PTK2. This antibody recognizes Human, Mouse, and Rat antigen. The FAK(Ab-397) Antibody has been validated for the following applications: Western Blot.

Product Specs
ItemFAK(Ab-397) Antibody
CompanySignalway Antibody LLC
Price Pricing Info Supplier Page View Company Product Page
Catalog Number21208
Quantity50ul
ApplicationsWB
Concentration1.0mg/ml
Conjugate/TagUnconjugated
FormatSupplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol
PurityAntibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific peptide
ReactivityHu, Ms, Rt
Molecular Weight125
HostRabbit
ImmunogenPeptide-KLH
NCBI Full Gene Nameprotein tyrosine kinase 2
NCBI Gene AliasesFAK1, pp125FAK, FRNK, FADK 1, FAK, FADK, PPP1R71, p125FAK
ClonalityPolyclonal
ValidationAs per applications, See images, contact for clarifications
TargetFAK
Domain/Region/TerminusPeptide sequence around aa. 395~399 (D-D-Y-A-E) derived from Human FAK

Add to Compare List

Signalway Antibody LLC

Signalway Antibody LLC

6305 Ivy Lane, Suite 370

Greenbelt, Maryland 20770

United States

Phone: 1-301-446-2499
Fax: 1-301-446-2413

Email: info@signalwayantibody.com

Company Profile

Website: http://www.sabbiotech.com/

(1) Effect of cell culture density on dental pulp-derived mesenchymal stem cells with reference to osteogenic differentiationScientific reportsApril 1, 2019Noda S, Kawashima N, Yamamoto M, Hashimoto K, Nara K, Sekiya I, Okiji T.

(2) Luteolin reduces the invasive potential of malignant melanoma cells by targeting β3 integrin and the epithelial-mesenchymal transitionActa pharmacologica SinicaOctober 1, 2012Ruan JS, Liu YP, Zhang L, Yan LG, Fan FT, Shen CS, Wang AY, Zheng SZ, Wang SM, Lu Y.

(3) Inhibition of hypoxia-induced epithelial mesenchymal transition by luteolin in non-small cell lung cancer cellsMolecular medicine reportsJuly 1, 2012Ruan J, Zhang L, Yan L, Liu Y, Yue Z, Chen L, Wang AY, Chen W, Zheng S, Wang S, et al.

Be the First to Write a Review!